Ian W. Jeffrey
- Molecular Biology top 10%
- RNA regulation and disease 12
- RNA and protein synthesis mechanisms 8
- RNA Research and Splicing 4
- Cell death mechanisms and regulation 3
- CRISPR and Genetic Engineering 2
-
- interferon and immune responses 4
-
- Viral Infections and Immunology Research 2
-
- Viral-associated cancers and disorders 3
- Co-authors
- Michael J. ClemensMartin BushellSimon MorleyVirginia M. PainM J ClemensKen LaingTyson V. SharpMartin Schwemmle
- Journals
- Nucleic Acids Research (2 papers)FEBS Letters (3 papers)European Journal of Biochemistry (3 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Ian W. Jeffrey
19 papers receiving 925 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 692
- Immunology 198
- Cardiology and Cardiovascular Medicine 124
- Oncology 148
- Cancer Research 75
Countries citing papers authored by Ian W. Jeffrey
This map shows the geographic impact of Ian W. Jeffrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian W. Jeffrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian W. Jeffrey more than expected).
Fields of papers citing papers by Ian W. Jeffrey
This network shows the impact of papers produced by Ian W. Jeffrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian W. Jeffrey. The network helps show where Ian W. Jeffrey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian W. Jeffrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 10 | |
| 2 | 2003 | 0 | |
| 3 | 2003 | 22 | |
| 4 | 2002 | 99 | |
| 5 | 2002 | 22 | |
| 6 | Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase. | 2002 | 64 |
| 7 | 2000 | 41 | |
| 8 | 2000 | 196 | |
| 9 | 1999 | 12 | |
| 10 | 1998 | 20 | |
| 11 | 1996 | 9 | |
| 12 | 1995 | 6 | |
| 13 | 1995 | 103 | |
| 14 | 1994 | 52 | |
| 15 | 1994 | 51 | |
| 16 | 1993 | 155 | |
| 17 | 1993 | 6 | |
| 18 | 1993 | 33 | |
| 19 | 1990 | 33 | |
| 20 | 1985 | 5 |
About Ian W. Jeffrey
Ian W. Jeffrey is a scholar working on Molecular Biology, Immunology and Cell Biology, having authored 20 papers that have together received 939 indexed citations. Recurring topics across this work include RNA regulation and disease (12 papers), RNA and protein synthesis mechanisms (8 papers), interferon and immune responses (4 papers), RNA Research and Splicing (4 papers), Viral-associated cancers and disorders (3 papers), Cell death mechanisms and regulation (3 papers), Viral Infections and Immunology Research (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Molecular Biology (692 citations), Immunology (198 citations) and Cardiology and Cardiovascular Medicine (124 citations). Ian W. Jeffrey has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Michael J. Clemens, Martin Bushell, Simon Morley, Virginia M. Pain, M J Clemens, Ken Laing, Tyson V. Sharp, Martin Schwemmle, Vivienne J. Tilleray and Kurt Hilse. Their work appears in journals such as Nucleic Acids Research, FEBS Letters and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.